{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:35:58Z","timestamp":1740116158043,"version":"3.37.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001958","name":"Armstrong Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","brainanddevelopment.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.braindev.2024.07.002","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T02:53:27Z","timestamp":1722048807000},"page":"294-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of cannabidiol as a neuroprotective agent on neurodevelopmental impairment in rats with neonatal hypoxia"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0686-9893","authenticated-orcid":false,"given":"\u00c1ngela","family":"Hern\u00e1ndez-Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Marin-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-5043","authenticated-orcid":false,"given":"Carmen","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-3161","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Romo-Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2024.07.002_b0005","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2147\/NDT.S235165","article-title":"Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options","volume":"16","author":"Sadowska","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.braindev.2024.07.002_b0010","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamapediatrics.2017.1689","article-title":"Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment","volume":"171","author":"Novak","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.braindev.2024.07.002_b0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dmcn.12080","article-title":"An update on the prevalence of cerebral palsy: a systematic review and meta-analysis","volume":"55","author":"Oskoui","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.07.002_b0020","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ajog.2015.05.034","article-title":"Cerebral palsy: causes, pathways, and the role of genetic variants","volume":"213","author":"MacLennan","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.braindev.2024.07.002_b0025","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/ijerph15091899","article-title":"Implementation of the international classification of functioning, disability, and health (ICF) core sets for children and youth with cerebral palsy: global initiatives promoting optimal functioning","volume":"15","author":"Schiariti","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.braindev.2024.07.002_b0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10974-020-09577-4","article-title":"Novel insights into cerebral palsy","volume":"41","author":"Bartels","year":"2020","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.braindev.2024.07.002_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fneur.2014.00185","article-title":"Early diagnosis and early intervention in cerebral palsy","volume":"5","author":"Hadders-Algra","year":"2014","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2024.07.002_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12974-021-02078-2","article-title":"Activation of MC1R with BMS-470539 attenuates neuroinflammation via cAMP\/ PKA\/Nurr1 pathway after neonatal hypoxic-ischemic brain injury in rats","volume":"18","author":"Yu","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.braindev.2024.07.002_b0045","doi-asserted-by":"crossref","first-page":"6643171","DOI":"10.1155\/2021\/6643171","article-title":"Dexmedetomidine alleviates hypoxia-induced synaptic loss and cognitive impairment via inhibition of microglial NOX2 activation in the hippocampus of neonatal rats","volume":"2021","author":"Chen","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.braindev.2024.07.002_b0050","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2147\/JIR.S355489","article-title":"The anti-inflammatory effects of cannabidiol (CBD) on acne","volume":"15","author":"Peyravian","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.braindev.2024.07.002_b0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/antiox9010021","article-title":"Antioxidative and anti-inflammatory properties of cannabidiol","volume":"9","author":"Atalay","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.braindev.2024.07.002_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.618065","article-title":"Glial cells and their contribution to the mechanisms of action of cannabidiol in neuropsychiatric disorders","volume":"11","author":"Scarante","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.braindev.2024.07.002_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ijms22010019","article-title":"CB2 receptor in microglia: the guardian of self-control","volume":"22","author":"Komorowska-M\u00fcller","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.braindev.2024.07.002_b0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvp240","article-title":"CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages","volume":"84","author":"Han","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.braindev.2024.07.002_b0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnins.2017.00030","article-title":"Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target","volume":"11","author":"Cassano","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.braindev.2024.07.002_b0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.braindev.2024.07.002_b0085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11481-015-9591-3","article-title":"Activation of cannabinoid type two receptors (CB2) diminish inflammatory responses in macrophages and brain endothelium","volume":"10","author":"Persidsky","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.braindev.2024.07.002_b0090","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3389\/fphar.2019.01131","article-title":"Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats","volume":"10","author":"Cepri\u00e1n","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.braindev.2024.07.002_b0095","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/molecules25030496","article-title":"Abnormal cannabidiol affects production of pro-inflammatory mediators and astrocyte wound closure in primary astrocytic-microglial cocultures","volume":"25","author":"von Widdern","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.braindev.2024.07.002_b0100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ani9090686","article-title":"The endocannabinoid system of animals","volume":"9","author":"Silver","year":"2019","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.braindev.2024.07.002_b0105","doi-asserted-by":"crossref","first-page":"e83589","DOI":"10.1371\/journal.pone.0083589","article-title":"Creating rat model for hypoxic brain damage in neonates by oxygen deprivation","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.braindev.2024.07.002_b0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0269881112474524","article-title":"Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats","volume":"27","author":"Chagas","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.braindev.2024.07.002_b0115","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00213-022-06119-3","article-title":"Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses","volume":"239","author":"Umpierrez","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.braindev.2024.07.002_b0120","first-page":"55261","article-title":"Reflex testing in neonatal rat pups","author":"Nguyen","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.braindev.2024.07.002_b0125","doi-asserted-by":"crossref","first-page":"9.52.1","DOI":"10.1002\/cpns.10","article-title":"The revised neurobehavioral severity scale (NSS-R) for rodents","volume":"75","author":"Yarnell","year":"2016","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.braindev.2024.07.002_b0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.braindev.2024.07.002_b0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic\u2013ischemic newborn pigs: role of 5HT1A and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.braindev.2024.07.002_b0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/pr.2017.104","article-title":"Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets","volume":"82","author":"Arruza","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.braindev.2024.07.002_b0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1203\/PDR.0b013e3182276b11","article-title":"Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs","volume":"70","author":"Lafuente","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.braindev.2024.07.002_b0150","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.braindev.2024.07.002_b0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12264-011-1008-6","article-title":"Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury","volume":"27","author":"Alonso-Alconada","year":"2011","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.braindev.2024.07.002_b0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.braindev.2024.07.002_b0165","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40263-018-0550-4","article-title":"Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system","volume":"32","author":"Schonhofen","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.braindev.2024.07.002_b0170","doi-asserted-by":"crossref","first-page":"e93411","DOI":"10.1371\/journal.pone.0093411","article-title":"Comprehensive behavioural analysis of long evans and sprague-dawley rats reveals differential effects of housing conditions on tests relevant to neuropsychiatric disorders","volume":"9","author":"Turner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.braindev.2024.07.002_b0175","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia\u2013ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.braindev.2024.07.002_b0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1871527315666160927110305","article-title":"Neuroprotective effects of cannabidiol in hypoxic ischemic insult. The therapeutic window in newborn mice","volume":"16","author":"Mohammed","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.braindev.2024.07.002_b0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13760-020-01308-3","article-title":"Pathophysiology of hypoxic\u2013ischemic encephalopathy: a review of the past and a view on the future","volume":"120","author":"Greco","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.braindev.2024.07.002_b0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.braindev.2024.07.002_b0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.joim.2023.03.004","article-title":"Neuroprotective potential of cannabidiol: molecular mechanisms and clinical implications","volume":"21","author":"Tambe","year":"2023","journal-title":"J Integr Med"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:18:22Z","timestamp":1725581902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760424000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0387760424000974"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2024.07.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of cannabidiol as a neuroprotective agent on neurodevelopmental impairment in rats with neonatal hypoxia","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2024.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.  All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}